Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1963
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 3
1964 2
1965 2
1966 3
1967 2
1968 5
1969 1
1970 2
1971 1
1972 2
1973 3
1974 3
1975 6
1976 3
1977 4
1978 1
1979 3
1980 7
1981 5
1982 4
1983 13
1984 3
1985 5
1986 6
1987 6
1988 15
1989 13
1990 6
1991 11
1992 9
1993 23
1994 14
1995 12
1996 13
1997 17
1998 19
1999 19
2000 18
2001 18
2002 16
2003 19
2004 23
2005 27
2006 11
2007 19
2008 18
2009 10
2010 16
2011 18
2012 20
2013 6
2014 17
2015 8
2016 23
2017 16
2018 20
2019 12
2020 23
2021 23
2022 17
2023 12
2024 25
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

670 results

Results by year

Filters applied: . Clear all
Page 1
Atypical pneumonia: Pathophysiology, diagnosis, and treatment.
Miyashita N. Miyashita N. Respir Investig. 2022 Jan;60(1):56-67. doi: 10.1016/j.resinv.2021.09.009. Epub 2021 Nov 5. Respir Investig. 2022. PMID: 34750083 Review.
The most common causative organisms of atypical pneumonia are Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella species. The therapeutic approach for atypical pneumonias is different than that for typical pneumonia. ...On the contrary, …
The most common causative organisms of atypical pneumonia are Mycoplasma pneumoniae, Chlamydia pneumoniae, and L …
Mycoplasma pneumoniae from the Respiratory Tract and Beyond.
Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. Waites KB, et al. Clin Microbiol Rev. 2017 Jul;30(3):747-809. doi: 10.1128/CMR.00114-16. Clin Microbiol Rev. 2017. PMID: 28539503 Free PMC article. Review.
Mycoplasma pneumoniae is an important cause of respiratory tract infections in children as well as adults that can range in severity from mild to life-threatening. Over the past several years there has been much new information published concerning infections caused
Mycoplasma pneumoniae is an important cause of respiratory tract infections in children as well as adults that can range in se
Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children.
Tsai TA, Tsai CK, Kuo KC, Yu HR. Tsai TA, et al. J Microbiol Immunol Infect. 2021 Aug;54(4):557-565. doi: 10.1016/j.jmii.2020.10.002. Epub 2020 Oct 17. J Microbiol Immunol Infect. 2021. PMID: 33268306 Free article. Review.
Mycoplasma pneumoniae is a common pathogen that causes community-acquired pneumonia. In the past, M. pneumoniae was sensitive to macrolide antibiotics, and M. pneumoniae pneumonia (MPP) was usually a benign and self-limiting disease. ...M
Mycoplasma pneumoniae is a common pathogen that causes community-acquired pneumonia. In the past, M. pneumoniae
Global Trends in the Proportion of Macrolide-Resistant Mycoplasma pneumoniae Infections: A Systematic Review and Meta-analysis.
Kim K, Jung S, Kim M, Park S, Yang HJ, Lee E. Kim K, et al. JAMA Netw Open. 2022 Jul 1;5(7):e2220949. doi: 10.1001/jamanetworkopen.2022.20949. JAMA Netw Open. 2022. PMID: 35816304 Free PMC article.
IMPORTANCE: The proportion of macrolide-resistant Mycoplasma pneumoniae (MRMP) infections has changed, and it differs according to geographical region. ...The presence of MRMP infection was defined as any case of M pneumoniae infection positive for any varian …
IMPORTANCE: The proportion of macrolide-resistant Mycoplasma pneumoniae (MRMP) infections has changed, and it differs accordin …
Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia.
Chen YC, Hsu WY, Chang TH. Chen YC, et al. Emerg Infect Dis. 2020 Jul;26(7):1382-1391. doi: 10.3201/eid2607.200017. Emerg Infect Dis. 2020. PMID: 32568052 Free PMC article.
A high prevalence rate of macrolide-resistant Mycoplasma pneumoniae (MRMP) has been reported in Asia. We performed a systematic review and meta-analysis to investigate the effect of macrolide resistance on the manifestations and clinical judgment during M. pneumo
A high prevalence rate of macrolide-resistant Mycoplasma pneumoniae (MRMP) has been reported in Asia. We performed a systemati …
Community-acquired pneumonia: An overview.
Mandell LA. Mandell LA. Postgrad Med. 2015 Aug;127(6):607-15. doi: 10.1080/00325481.2015.1074030. Postgrad Med. 2015. PMID: 26224210 Free PMC article. Review.
Community-acquired pneumonia is still a significant cause of morbidity and mortality and is often misdiagnosed and inappropriately treated. Although it can be caused by a wide variety of micro-organisms, the pneumococcus, atypicals, such as Mycoplasma pneumoniae
Community-acquired pneumonia is still a significant cause of morbidity and mortality and is often misdiagnosed and inappropriately tr …
Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis.
Ahn JG, Cho HK, Li D, Choi M, Lee J, Eun BW, Jo DS, Park SE, Choi EH, Yang HJ, Kim KH. Ahn JG, et al. BMC Infect Dis. 2021 Sep 25;21(1):1003. doi: 10.1186/s12879-021-06508-7. BMC Infect Dis. 2021. PMID: 34563128 Free PMC article.
BACKGROUND: Mycoplasma pneumoniae is a common pathogen that causes community-acquired pneumonia in school-age children. Macrolides are considered a first-line treatment for M. pneumoniae infection in children, but macrolide-refractory M. pneumoniae
BACKGROUND: Mycoplasma pneumoniae is a common pathogen that causes community-acquired pneumonia in school-age children. …
Mycoplasma Pneumonia in Children and Adolescents.
Krafft C, Christy C. Krafft C, et al. Pediatr Rev. 2020 Jan;41(1):12-19. doi: 10.1542/pir.2018-0016. Pediatr Rev. 2020. PMID: 31894069 Review. No abstract available.
Insight into the Pathogenic Mechanism of Mycoplasma pneumoniae.
Hu J, Ye Y, Chen X, Xiong L, Xie W, Liu P. Hu J, et al. Curr Microbiol. 2022 Dec 2;80(1):14. doi: 10.1007/s00284-022-03103-0. Curr Microbiol. 2022. PMID: 36459213 Free PMC article. Review.
Mycoplasma pneumoniae, an obligate parasitic pathogen without cell wall, can cause severe upper and lower respiratory tract symptoms. It is the pathogen of human bronchitis and walking pneumonia, and named community-acquired pneumonia. In addition to s
Mycoplasma pneumoniae, an obligate parasitic pathogen without cell wall, can cause severe upper and lower respiratory tract sy
Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia.
Ding G, Zhang X, Vinturache A, van Rossum AMC, Yin Y, Zhang Y. Ding G, et al. Eur J Pediatr. 2024 Jul;183(7):3001-3011. doi: 10.1007/s00431-024-05519-1. Epub 2024 Apr 18. Eur J Pediatr. 2024. PMID: 38634891 Review.
Mycoplasma pneumoniae (MP) is an important cause of community-acquired pneumonia in children and young adolescents. ...Macrolide-resistant and refractory MP pneumonia are two conditions that may complicate the clinical course of MP pneumonia, in
Mycoplasma pneumoniae (MP) is an important cause of community-acquired pneumonia in children and young adolescents. ...
670 results